Calicheamicin

CAT:
804-HY-19609-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Calicheamicin - image 1

Calicheamicin

  • Description :

    Calicheamicin, an antitumor antibiotic, is a cytotoxic agent that causes double-strand DNA breaks. Calicheamicin is a DNA synthesis inhibitor[1]. Calicheamicin is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
  • Product Name Alternative :

    Calicheamicin γ1
  • UNSPSC :

    12352203
  • Hazard Statement :

    H300+H330, H340, H360, H370, H372, H412
  • Target :

    ADC Payload; Antibiotic; Apoptosis; Bacterial; DNA Alkylator/Crosslinker
  • Type :

    ADC Related
  • Related Pathways :

    Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Cell Cycle/DNA Damage
  • Applications :

    Cancer-programmed cell death
  • Field of Research :

    Cancer; Infection
  • Assay Protocol :

    https://www.medchemexpress.com/Calicheamicin.html
  • Purity :

    98.92
  • Solubility :

    DMSO : 25 mg/mL (ultrasonic)
  • Smiles :

    O[C@](CC1=O)(C#C/C=C\C#C2)/C(C([C@H]2O[C@@](O[C@H](C)[C@@H](NO[C@H](O[C@H](C)[C@H]3SC(C(C(C)=C(I)C(O[C@H](O[C@@H](C)[C@H](O)[C@H]4OC)[C@@H]4O)=C5OC)=C5OC)=O)C[C@@H]3O)[C@@H]6O)([H])[C@@H]6O[C@@](OC[C@@H]7NCC)([H])C[C@@H]7OC)=C1NC(OC)=O)=C/CSSSC
  • Molecular Formula :

    C55H74IN3O21S4
  • Molecular Weight :

    1368.35
  • Precautions :

    H300+H330, H340, H360, H370, H372, H412
  • References & Citations :

    [1]Damelin M, et al. Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions. Clin Cancer Res. 2015 Sep 15;21 (18) :4165-73|[2]de Vries JF, et al. The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells. Leukemia. 2012 Feb;26 (2) :255-64|[3]Takeshita A, et al. CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells. Leukemia. 2009 Jul;23 (7) :1329-36.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    ADC Related
  • Clinical Information :

    No Development Reported
  • Isoform :

    Calicheamicins
  • CAS Number :

    [108212-75-5]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide